Femasys Inc
NASDAQ:FEMY
Femasys Inc
Total Receivables
Femasys Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Femasys Inc
NASDAQ:FEMY
|
Total Receivables
$98.9k
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Receivables
$2.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Total Receivables
$3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Total Receivables
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Total Receivables
$124.4m
|
CAGR 3-Years
85%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
See Also
What is Femasys Inc's Total Receivables?
Total Receivables
98.9k
USD
Based on the financial report for Dec 31, 2023, Femasys Inc's Total Receivables amounts to 98.9k USD.
What is Femasys Inc's Total Receivables growth rate?
Total Receivables CAGR 3Y
-9%
Over the last year, the Total Receivables growth was 24%. The average annual Total Receivables growth rates for Femasys Inc have been -9% over the past three years .